↓ Skip to main content

The clinical efficacy and safety of dapagliflozin in patients with diabetic nephropathy

Overview of attention for article published in Diabetology & Metabolic Syndrome, March 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
10 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The clinical efficacy and safety of dapagliflozin in patients with diabetic nephropathy
Published in
Diabetology & Metabolic Syndrome, March 2022
DOI 10.1186/s13098-022-00815-y
Pubmed ID
Authors

Ying Huang, Wen Lu, Hongyun Lu

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 1 10%
Student > Bachelor 1 10%
Student > Postgraduate 1 10%
Unknown 7 70%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 2 20%
Biochemistry, Genetics and Molecular Biology 1 10%
Unknown 7 70%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 March 2022.
All research outputs
#18,931,665
of 23,460,553 outputs
Outputs from Diabetology & Metabolic Syndrome
#494
of 704 outputs
Outputs of similar age
#317,955
of 443,197 outputs
Outputs of similar age from Diabetology & Metabolic Syndrome
#19
of 27 outputs
Altmetric has tracked 23,460,553 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 704 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.7. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 443,197 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.